


Anthem Blue Cross Blue Shield Reverses Anesthesia Policy Amid Outrage Following CEO Shooting
Anthem Blue Cross Blue Shield halts controversial anesthesia reimbursement policy after backlash linked to public outrage over UnitedHealthcare CEO's assassination.
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get StartedAlready subscribed? Sign in
Overview
Anthem Blue Cross Blue Shield has decided not to move forward with a controversial policy to cap anesthesia reimbursements based on surgical durations, a reversal following public uproar after the assassination of UnitedHealthcare CEO Brian Thompson. The insurer faced significant pushback, particularly from the American Society of Anesthesiologists, and accusations of inadequate patient care. In response to the backlash and political intervention from New York and Connecticut officials, Anthem clarified their commitment to covering medically necessary anesthesia services.
Content generated by AI—learn more or report issue.

Get both sides in 5 minutes with our daily newsletter.
Analysis
Analysis unavailable for this viewpoint.
Articles (31)
Center (15)
History
- 7M4 articles